• Distinct Mechanisms of Chuanxiong Cortex and Pith in CHD The

  2026-06-04

  This study employs SPME-GC×GC-MS and network pharmacology to dissect the distinct bioactive components and molecular pathways of Chuanxiong’s rhizome cortex and pith in coronary heart disease (CHD) prevention. The findings advance understanding of tissue-specific compound distribution and support precision strategies for optimizing traditional herbal interventions.

• Translatome Remodeling by Fatty Acids Drives Ketogenesis and

  2026-06-04

  The referenced Nature study reveals that fasting-induced long-chain fatty acids, including linoleic acid (C18:2(9Z,12Z)), activate an AMPK-MNK-eIF4E axis in hepatocytes, selectively remodeling the translatome to promote ketogenesis even as global protein synthesis declines. This mechanism links dietary lipids to translation control and identifies a targetable vulnerability in pancreatic cancer, highlighting new directions for metabolic and cancer research.

• Staurosporine as a Broad-Spectrum Kinase Inhibitor in Cancer

  2026-06-03

  Staurosporine stands out as a gold-standard, broad-spectrum serine/threonine protein kinase inhibitor for apoptosis induction and kinase signaling dissection in cancer research. Explore advanced workflows, protocol optimizations, and troubleshooting insights that maximize experimental impact with APExBIO’s trusted reagent.

• Applied Strategies with the HyperScribe T7 High Yield Cy5 RN

  2026-06-03

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit from APExBIO delivers robust, customizable fluorescent RNA probe synthesis for high-sensitivity applications. This guide distills best practices, workflow enhancements, and troubleshooting insights for researchers seeking reliable, high-yield Cy5 RNA labeling.

• Sulfo-NHS-Biotin: Precision Protein Biotinylation for Single

  2026-06-02

  Discover how Sulfo-NHS-Biotin empowers advanced protein labeling in high-resolution single-cell secretome profiling. This article provides unique, practical insight into robust assay design, bridging molecular technique with the latest single-cell innovations.

• Clathrin-Mediated Endocytosis Drives GCRV104 Entry in Fish C

  2026-06-02

  Wang et al. (2018) identified clathrin-mediated endocytosis as the primary route for genotype III grass carp reovirus (GCRV104) entry into kidney-derived CIK cells. Their pharmacological inhibitor analysis demonstrates that actin cytoskeleton disruption does not impair viral entry, refining experimental approaches in aquatic virology and cytoskeletal research.

• VX-765: Precision Caspase-1 Inhibition for Inflammation Rese

  2026-06-01

  VX-765 empowers translational researchers with potent, selective caspase-1 inhibition, streamlining workflows in inflammation and pyroptosis studies. Its oral bioavailability and robust selectivity make it a gold standard for dissecting cytokine release and cell death pathways across disease models.

• Solving RNA Probe Labeling with HyperScribe™ T7 High Yield C

  2026-06-01

  This article offers practical, evidence-backed strategies for overcoming common RNA probe labeling challenges in cell-based assays, centering on the HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit (SKU K1062). Drawing on real laboratory scenarios, protocol parameters, and quantitative data, we highlight how this kit streamlines fluorescent RNA probe synthesis for applications such as in situ hybridization and Northern blotting, ensuring reproducibility and sensitivity for demanding biomedical research workflows.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance in Allergic

  2026-05-31

  This study investigates Shufeng Xingbi Therapy (SFXBT) in a rat model of allergic rhinitis, revealing its capacity to rebalance Th1/Th2 immune responses and reshape the intestinal microbiota. The work offers mechanistic insight into how SFXBT may alleviate allergic inflammation by targeting both immune and microbial components.

• Metabolomic Biomarkers Reveal Carbapenem Resistance in Enter

  2026-05-30

  This study applies LC-MS/MS metabolomics to distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE strains, identifying 21 metabolic biomarkers predictive of resistance. The findings advance rapid diagnostics and deepen our understanding of resistance mechanisms, with direct implications for antibiotic resistance studies and translational workflows.

• Optimizing Tumor Microenvironment Assays with Talabostat Mes

  2026-05-29

  This article explores laboratory scenarios where Talabostat mesylate (SKU B3941) provides robust solutions for DPP4 and FAP inhibition in cancer and immunology assays. By addressing real-world experimental challenges and integrating current literature, we highlight how SKU B3941 supports reproducibility and workflow efficiency for bench scientists and biomedical researchers.

• U-73122: Precision Phospholipase C Inhibitor for Cancer and

  2026-05-29

  U-73122 stands out as a highly selective phospholipase C inhibitor, enabling precise dissection of PLC signaling in cancer, inflammation, and migration studies. This article translates cutting-edge research into actionable workflows and troubleshooting strategies for maximizing reproducibility and insight.

• Paclitaxel (Taxol) in Advanced Cancer Research Models

  2026-05-28

  Paclitaxel (Taxol) enables precise control of cell cycle arrest and apoptosis in next-generation cancer research platforms. Discover how to leverage its robust properties in advanced assembloid models, optimize protocols, and troubleshoot common pitfalls for high-impact translational results.

• Tigecycline: Mechanisms, MDR Dynamics, and Future Resistance

  2026-05-28

  Explore how Tigecycline, a pioneering glycylcycline antibiotic, uniquely addresses multidrug-resistant bacteria through advanced mechanisms and resistance gene insights. This article offers a deeper scientific analysis and strategic guidance for researchers confronting evolving MDR threats.

• Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re

  2026-05-27

  Staurosporine stands out as a potent, broad-spectrum serine/threonine protein kinase inhibitor, enabling precise apoptosis induction and pathway dissection in cancer research. Discover how optimized workflows, troubleshooting strategies, and insights from the latest liver disease studies empower reliable, reproducible results with APExBIO’s Staurosporine.

556 records 16/38 page Previous Next First page 上5页 1617181920 下5页 Last page